MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, IGMS made $143,623K in revenue. $97,584K in net income. Net profit margin of 67.94%.

Income Overview

Revenue
$143,623K
Net Income
$97,584K
Net Profit Margin
67.94%
EPS
$1.58
Unit: Thousand (K) dollars

Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Collaboration revenue
143,623 499 1,131* 516
General and administrative
9,581 11,049 -5,878* 18,761
Research and development
5,863 22,337 22,428* 46,142
Impairment and disposal of long-lived assets
31,917 21,889 --
Total operating expenses
47,361 55,275 16,550* 64,903
Income (loss) from operations
96,262 -54,776 -15,419* -64,387
Interest income
1,322 -3,914 2,957
Total other income
1,322 -3,914* 2,957
Loss before income tax expense
---11,505 -61,430
Net income (loss)
97,584 --11,505 -61,430
Basic EPS
1.59 -0.86 -0.191 -1.01
Diluted EPS
1.58 -0.86 -0.191 -1.01
Basic Average Shares
61,462,957 61,162,762 60,371,295 60,657,797
Diluted Average Shares
61,751,283 61,162,762 60,371,295 60,657,797
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Collaboration revenue$143,623K Interest income$1,322K Income (loss) fromoperations$96,262K Total other income$1,322K Total operatingexpenses$47,361K Net income (loss)$97,584K Impairment and disposal oflong-lived assets$31,917K General andadministrative$9,581K Research and development$5,863K

IGM Biosciences, Inc. (IGMS)

IGM Biosciences, Inc. (IGMS)